My 10 Top Stocks to Buy to Start the New Year Off Right
But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...
CNBC on MSN23d
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions – NBC Los Angeles
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
AOL20d
What is Compounded Tirzepatide? Here's What You Need to Know
Compounded tirzepatide isn’t FDA-approved. This means there’s no guarantee it’s safe or effective. If you’re considering it, go to a safe source. Just because you can buy tirzepatide ...
Don't Buy Weight-Loss Medication From Unauthorized Sources, UK Health Agency Warns About Risks
As the New Year begins, the U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) is urging the public to avoid ...
Hims & Hers in focus as Eli Lilly obesity drug sales disappoint
Eli Lilly (LLY) stock fell as its obesity therapy tirzepatide missed forecasts, amid focus on compounded weight loss ...
Hosted on MSN23d
Does This News From the FDA Make Eli Lilly a Buy for 2025?
Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks » The supply problem has been one of the biggest risks for Lilly. With the tirzepatide ...